DNAprint Genomics (DNAG)

[Blue Juggernaut]

Dear Dnaowner,

I believe that you are referencing the upgrade of the Beckman Coulter GenomeLab. From data points from Tony and Money’s report of Trace, DNAG is reportedly flooded with work. The upgrade obviously cost money but I do believe that this could be a good purchase if the aforementioned data points continue to hold true. This is not a question of veracity but a question of sustained work. With sustained and incremental increases in work the breakeven moves up on the cost benefit analysis that DNAG hopefully did prior to the purchase and your efficiencies will really materialize. Contrary, if the work in is not sustained than you have a great & fast machine but all day to run the job(s)….the machine would sit idol most of the day.

I hope that you are right and there is a major bottleneck.
Big Blue